Best Medicines Coalition
Add to list
The Best Medicines Coalition is a national alliance of patient organizations with a shared goal of equitable and consistent access for all Canadians to safe and effective medicines that improve patient outcomes. The BMC’s areas of interest include drug approval, assessment and reimbursement, as well as patient safety and supply issues. As an important aspect of its work, the BMC strives to ensure that Canadian patients have a voice and are meaningful participants in health policy development, specifically regarding pharmaceutical care.
Input to the PMPRB regarding development of new Guidelines Introduction
19 Dec 2023
Drug Supply: Improving access to drugs and other health products in Canada
31 Aug 2023
pan-Canadian Temporary Access Process: Best Medicines Coalition Position Points
21 Aug 2023
Health Canada Consultation: Proposed agile regulations and guidance for...
26 Apr 2023
Submission to the Standing Committee on Health: Patented Medicine Prices...
25 Apr 2023
Submission to Finance Canada: Priorities for the Federal Budget (February 10, 2023)
9 Feb 2023
BMC’s Submission on the National Strategy for Drugs for Rare Diseases —...
15 Aug 2022
Submission to Finance Canada: Priorities for the Federal Budget (February 25, 2022)
24 Feb 2022